Using a total of 159 glioblastoma patients dichotomized by the median of ABCG1 expression, there were no significant survival differences between patients harboring gliomas with low versus high ABCG1 gene expression (Figure 1B). The gene discussed is ABCG1; the disease is central nervous system cancer.